2 top growth stocks I’d buy in December

Recent news makes Paul Summers bullish on these top growth plays.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in cellular materials technology company Zotefoams (LSE: ZOTE) jumped 17% in early trading after the small-cap announced a mouthwatering strategic partnership with US sports giant Nike.

In addition to collaborating on developing footwear technology, the Croydon-based business has agreed to supply the $100bn cap firm with its “high-performance foam materials“. These — the former claims — are not only superior “in performance, consistency, quality and purity” to those produced through alternative methods, but can also be formulated to client specifications. 

Today’s hugely encouraging news builds on the positive trading update released by the company at the start of November.

Back then, it was announced that group revenue had been 22% higher in Q3 than over the same period in 2016 (and 24% ahead over the first nine months of 2017) as a result of “strong organic growth across all business units“. Sales rose 16% over the quarter once currency fluctuations had been taken into account.

Thanks to this excellent performance and a bulging order book, full-year revenues at Zotefoams are now likely to come in ahead of market expectations. Adjusted profit before tax and exceptional items is also forecast to be at “the top end of the range” of analyst predictions.

Taking today’s rise into account, Zotefoams’ share price is 92% up from exactly one year ago. As you might expect, that means the stock isn’t quite the bargain it once was. A forecast price-to-earnings (P/E) ratio of 26 for the full year certainly leaves little room for error.

Nevertheless, this morning’s news — combined with the firm’s strategy of increasing investment in new equipment with the intention of becoming a global leader in what it does — suggests to me that it is still worthy of serious consideration by growth-focused Fools.

Game on

Also announcing news today was £900m cap technical services provider Keywords Studios (LSE: KWS) — one of the standout performers of the junior market in 2017.

Acquisition-friendly Keywords informed investors that it had purchased game development, art creation and software engineering firm Sperasoft for $27m as part of its ongoing strategy to “selectively consolidate the highly fragmented market for video games services.” Funded from a combination of existing resources and equity, this new addition to the Dublin-based firm’s portfolio is expected to be earnings enhancing in the first year. 

A quick scan of Sperasoft’s recent performance goes some way to explaining why Keywords was so keen to take the US-headquartered company under its wing.

Thirteen years after its inception, the company employs 400 members of staff and boasts production studios in Russia and Poland. In 2016, it achieved revenues of $16m — 54% higher than in 2015. This number is expected to grow to roughly $20m in the current year, with underlying adjusted EBITDA of $2m. Sperasoft’s enviable list of clients includes Electronic Arts (developer and publisher of top sporting titles including Fifa), Ubisoft (maker of newly-released Assassin’s Creed: Origins), Warner Bros and Riot Games.  

Trading on a nosebleed-inducing valuation of 58 times earnings for the current year (reducing to 41 in 2018 if earnings growth estimates are hit), Keywords is clearly priced to perfection. 

That said, with the popularity of gaming showing no signs of slowing and the company quickly establishing itself as the global go-to destination for services in the industry, I still regard it as an exception to the rule that hyper-expensive stocks are simply too risky to be worth bothering with.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers owns shares in Keyword Studios. The Motley Fool UK has recommended Keywords Studios. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Black man sat in front of laptop while wearing headphones
Investing Articles

Down 53% in a year! I reckon this oversold FTSE 100 stock is now ripe for a comeback

This FTSE 100 stock has fallen out of fashion with investors, but Harvey Jones reckons the sell-off has gone too…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

How much second income would I get if I put £10k into dirt cheap Centrica shares?

Centric shares have been looking incredibly cheap despite rocketing in recent years. Harvey Jones wonders whether this is an opportunity…

Read more »

artificial intelligence investing algorithms
Investing Articles

If I’d invested £10k in AstraZeneca shares three months ago here’s what I’d have now

Harvey Jones is kicking himself for failing to buy AstraZeneca shares before the took off. Is there still a decent…

Read more »

A senior group of friends enjoying rowing on the River Derwent
Investing Articles

How I’d find shares to buy for an early retirement

Christopher Ruane explains some of the factors he considers when looking for shares to buy that could potentially help him…

Read more »

Investing Articles

Why I’d snap up bargain UK shares to try and build wealth

Christopher Ruane explains how he hopes to find high-quality UK shares selling at attractive prices, to help him build wealth…

Read more »

Young Caucasian woman at the street withdrawing money at the ATM
Investing Articles

Here’s how I’d target a £2k annual second income from a £20k Stocks & Shares ISA

Our writer explains how he’d try to earn thousands of pounds annually in dividends by investing a £20k ISA in…

Read more »

Mother and Daughter Blowing Bubbles
Investing Articles

5 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Investing Articles

The £20k Stocks and Shares ISA might be one of the better things about living in the UK

The £20k Stocks and Shares ISA doesn't have many equivalents in other countries. Here's why these accounts can help UK…

Read more »